Skip to main content
Clinical Trials/NCT01076673
NCT01076673
Completed
Phase 2

Articular Cartilage Regeneration With Autologous Peripheral Blood Stem Cells Versus Hyaluronic Acid: A Randomized, Controlled Trial

Kuala Lumpur Sports Medicine Centre1 site in 1 country50 target enrollmentOctober 2009

Overview

Phase
Phase 2
Intervention
Peripheral blood stem cells and hyaluronic acid injections
Conditions
Articular Cartilage Disorder of Knee
Sponsor
Kuala Lumpur Sports Medicine Centre
Enrollment
50
Locations
1
Primary Endpoint
Change in tissue histology after subchondral drilling surgery using serial MRI scanning and cartilage biopsies
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

The purpose of this study was to compare histologic and MRI evaluation of articular cartilage regeneration in patients with chondral lesions treated by arthroscopic subchondral drilling followed by postoperative intra-articular injections of hyaluronic acid (HA) with and without peripheral blood stem cells (PBSC)

Detailed Description

The purpose of this study was to compare histologic and magnetic resonance imaging (MRI) evaluation of articular cartilage regeneration in patients with chondral lesions treated by arthroscopic subchondral drilling followed by postoperative intra-articular injections of hyaluronic acid (HA) with and without peripheral blood stem cells (PBSC)

Registry
clinicaltrials.gov
Start Date
October 2009
End Date
May 2012
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Kuala Lumpur Sports Medicine Centre
Responsible Party
Principal Investigator
Principal Investigator

Dr. Khay-Yong Saw

Consultant Orthopaedic Surgeon

Kuala Lumpur Sports Medicine Centre

Eligibility Criteria

Inclusion Criteria

  • Patients who have signed informed consent form
  • Patients with only unilateral isolated or multiple knee articular cartilage lesions demonstrated MRI scanning, with up to one previous operation on that knee
  • Patients who are either male or female aged between 18 to 50 years old, corresponding to availability of normative International Knee Documentation Committee (IKDC) data.
  • Female patients of childbearing age must have negative pregnancy tests and are advised to take contraceptive precautions throughout the study.

Exclusion Criteria

  • Patients with bilateral knee lesions
  • Patients with the presence of ligamentous injury which would require reconstruction, varus or valgus deformity greater than 10 degrees, previous open total menisectomy requiring osteotomy, and cases that require complex surgery prior to cartilage regeneration
  • Patients with significant cognitive impairment, non-ambulatory status or lower extremities amputation other than toes, serious illness or medication affecting operative risk or wound healing (e.g. steroid intake, anticoagulation), and poorly controlled diabetes mellitus with a baseline HbA1c more than 8
  • Patients with significant peripheral vascular disease as indicated by absent dorsalis pedis or posterior tibial pulses.
  • Patients who cannot read English will be excluded from the study as they will be unable to complete the study questionnaires in an objective manner
  • Female patients who are pregnant
  • Patients with any contradictions to MRI scanning
  • Patients with body mass index (BMI) of over 35

Arms & Interventions

PBSC and Hyaluronic Acid

Peripheral blood stem cells and hyaluronic acid injections

Intervention: Peripheral blood stem cells and hyaluronic acid injections

Hyaluronic Acid

Hyaluronic Acid

Intervention: Hyaluronic Acid

Outcomes

Primary Outcomes

Change in tissue histology after subchondral drilling surgery using serial MRI scanning and cartilage biopsies

Time Frame: 18 months

Secondary Outcomes

  • Improved long term functional outcome of subchondral drilling surgery in the knee joint(18 months)

Study Sites (1)

Loading locations...

Similar Trials